AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
Authors
Keywords
-
Journal
CELLULAR ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-27
DOI
10.1007/s13402-021-00645-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PI3K /Akt/ mTORC signaling axis in head and neck squamous cell carcinoma: possibilities for therapeutic interventions either as single agents or in combination with conventional therapies
- (2021) Nader Akbari Dilmaghani et al. IUBMB LIFE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells
- (2021) Mehmet Bugrahan Duz et al. MOLECULAR BIOLOGY REPORTS
- Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma
- (2020) Yu Jin et al. BIOSCIENCE REPORTS
- In silico models accurately predict in vivo response for IL-6 blockade in head and neck cancer
- (2020) Fereshteh Nazari et al. CANCER RESEARCH
- An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
- (2020) Mei-Yu Quan et al. Frontiers in Cell and Developmental Biology
- FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen
- (2020) Dimo Dietrich HNO
- Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness
- (2020) Louise Flynn et al. Scientific Reports
- Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
- (2020) Attia M. Elbehi et al. ORAL ONCOLOGY
- Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile
- (2020) Cinzia Federico et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Implications of fibroblast growth factor (FGF) in cancer: From prognostics to therpeutic applications
- (2019) Hassan Dianat-Moghadam et al. CURRENT DRUG TARGETS
- Hedychium coronarium extract arrests cell cycle progression, induces apoptosis, and impairs migration and invasion in HeLa cervical cancer cells
- (2019) Asit Ray et al. Cancer Management and Research
- miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1
- (2019) Limin Huang et al. EXPERIMENTAL CELL RESEARCH
- Immunotherapy for Head and Neck Cancer
- (2019) Felix Sim et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment
- (2019) Jinho Kang et al. Scientific Reports
- Transgelin 2 promotes paclitaxel resistance, migration and invasion of breast cancer by directly interacting with PTEN and activating PI3K/Akt/GSK-3β pathway
- (2019) Leichao Liu et al. MOLECULAR CANCER THERAPEUTICS
- Down-regulation of UTP23 promotes paclitaxel resistance and predicts poorer prognosis in ovarian cancer
- (2019) Zhiqin Fu et al. PATHOLOGY RESEARCH AND PRACTICE
- RIG‐I promotes IFN/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma
- (2019) Di Jing et al. Cancer Medicine
- High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment
- (2019) Zuping Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer
- (2019) Franziska E. Marquard et al. BIOCHEMICAL PHARMACOLOGY
- Targetedregulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1
- (2018) Jie Gao et al. Cancer Biomarkers
- Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
- (2018) Dongshao Chen et al. Cell Death & Disease
- Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway
- (2018) Yuqi Wu et al. OncoTargets and Therapy
- Bcl‐2 inhibitors enhance FGFR inhibitor‐induced mitochondrial‐dependent cell death in FGFR 2 mutant endometrial cancer
- (2018) Leisl M. Packer et al. Molecular Oncology
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro
- (2017) Roman C. Brands et al. ONCOLOGY REPORTS
- Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential
- (2017) Bok Hee Woo et al. Oncotarget
- Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
- (2017) Jorge Gómez-Miragaya et al. Stem Cell Reports
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
- (2016) K. Koole et al. CLINICAL CANCER RESEARCH
- Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma
- (2016) Naoshad Muhammad et al. CLINICAL CANCER RESEARCH
- Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
- (2016) Jason S. L. Yu et al. DEVELOPMENT
- SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway
- (2016) Weipeng Zhang et al. JOURNAL OF DRUG TARGETING
- Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
- (2016) H Cocks et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
- (2016) Stephen B. Keysar et al. JNCI-Journal of the National Cancer Institute
- Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells
- (2016) S Schneider et al. ORAL DISEASES
- Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways
- (2016) Chen Qiong Xie et al. Oncology Letters
- Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo
- (2016) Chun-Han Chen et al. Oncotarget
- A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth
- (2016) Jihyun Park et al. Oncotarget
- The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck
- (2016) Mayur D. Mody et al. JAMA Otolaryngology-Head & Neck Surgery
- Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
- (2016) Stephen B. Keysar et al. JNCI-Journal of the National Cancer Institute
- Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
- (2015) Yu Yu et al. CANCER CELL
- Targeting FGFR Signaling in Cancer
- (2015) M. Touat et al. CLINICAL CANCER RESEARCH
- The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
- (2015) Zhi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway
- (2015) Yang Li et al. TUMOR BIOLOGY
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Taxanes in cancer of the head and neck
- (2014) Krzysztof Misiukiewicz et al. ANTI-CANCER DRUGS
- Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma
- (2014) Christian Freudlsperger et al. INTERNATIONAL JOURNAL OF CANCER
- Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma
- (2014) Naoshad Mohammad et al. Molecular Cancer
- Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
- (2014) DONG LI et al. Molecular Medicine Reports
- Ephrin type-A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3-kinase/Akt signalling pathway
- (2014) YUNYUN WANG et al. Molecular Medicine Reports
- Combination of Taxol® and dichloroacetate results in synergistically inhibitory effects on Taxol-resistant oral cancer cells under hypoxia
- (2014) QI XIE et al. Molecular Medicine Reports
- Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
- (2014) P Ramos et al. ONCOGENE
- Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis
- (2014) Xiangpeng Dai et al. Cancer Medicine
- Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
- (2013) R. Dienstmann et al. ANNALS OF ONCOLOGY
- PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
- (2013) Atish Patel et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway
- (2012) Yeong-In Yang et al. CARCINOGENESIS
- Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy
- (2012) V Roulstone et al. GENE THERAPY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis
- (2011) Xuefeng Fang et al. BMC GENOMICS
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells
- (2011) M. E. Marshall et al. CLINICAL CANCER RESEARCH
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
- (2011) Marta M. Alonso et al. PLoS One
- Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
- (2010) Y.-j. Mi et al. CANCER RESEARCH
- Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
- (2010) E. M. Haugsten et al. MOLECULAR CANCER RESEARCH
- Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
- (2010) D. Pulte et al. ONCOLOGIST
- E2F1 in Melanoma Progression and Metastasis
- (2009) Vijay Alla et al. JNCI-Journal of the National Cancer Institute
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now